Photo: Cystic Fibrosis NZ
Cystic fibrosis drugs Trikafta and Alyftrek could become available for all children, regardless of age, with drug-buying agency Pharmac opening consultation on funding the two drugs.
Currently only funded for children aged six and over, Pharmac is consulting on making Trikafta available for all children with an eligible diagnosis
Continue Reading on RNZ
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.